Therefore, further research into the molecular mechanisms of granzyme-induced apoptosis, especially the role of GZMK in breast cancer, is crucial for advancing our understanding of breast cancer immunotherapy and enhancing the reliability of clinical evidence for its treatment. This evidence concerns the gene GZMK and breast carcinoma.